Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...

Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 ...

HealthDay News — For patients with obesity, the addition of semaglutide to standard hidradenitis suppurativa (HS) treatments yields improvement in quality of life and a reduction in flares, according ...

Semaglutide for obesity was associated with superior weight reduction and glycemic control among patients with obesity and prediabetes.

A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.

When we talk about GLP-1 medications, we're usually focused on weight loss or the drug's side effects (we're looking at you, ...

A pioneering study, presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates ...

A pioneering study, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the ...

A study compared the association of semaglutide vs other antidiabetic medications and other GLP-1RAs, including liraglutide ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Semaglutide – a key ingredient in Ozempic and Wegovy – was associated with a lower risk of opioid overdose in patients with ...